Granted Patent B2

US 12,352,719 · App. 17/024,811 · Granted Jul 8, 2025

Inventors: Craig W. Nies (Greenville, SC); Hari Kishan Rao Abbaraju (Simpsonville, SC)

Assignee: KYCERA AVX Components Corporation

G01N27/327C01B32/158C01B32/182C01G7/00G01N27/305

Abstract

Claims (30)

1. A biosensor for detecting transepithelial/transendothelial electrical resistance comprising:

at least one substrate;

an adhesion layer that overlies the at least one substrate, wherein the adhesion layer includes tantalum, chromium, tantalum nitride, tungsten-titanium, titanium, titanium nitride, or a combination thereof;

a working electrode that overlies the adhesion layer and is formed on at least a portion of the at least one substrate, the working electrode comprising a biologically inert material, wherein the biologically inert material includes gold, graphene, carbon nanotubes, or a combination thereof;

a reference electrode that overlies the adhesion layer and is formed on the at least one substrate; and

a case, wherein the case defines side walls, a lower wall, and a channel, wherein the channel has a volume of about 150 microliters or less and contacts the working electrode, further wherein the channel extends between at least one inlet and at least one outlet, the at least one inlet having a tapered and/or conical shape and the at least one outlet having a tapered and/or conical shape, further wherein the at least one inlet and the at least one outlet have an innermost part and an outermost part, the outermost part of the at least one inlet and the at least one outlet having a larger diameter than the innermost part of the at least one inlet and the at least one outlet;

wherein the adhesion layer is positioned between the at least one substrate and the working electrode and/or the reference electrode;

wherein spino-cerebral endothelial cells are immobilized with at least one linking agent, wherein the at least one linking agent comprises a thiol, a pyrene, a diazonium, an azide, a sol-gel, or a combination thereof, and further wherein the at least one linking agent continuously covers a portion of a top surface of the working electrode, a side surface of the working electrode, and a portion of a top surface of the at least one substrate;

further wherein at least the portion of the working electrode wherein the spino-cerebral endothelial cells are immobilized is transparent having a percent transmittance of at least 80% but no more than about 99.9%; and

wherein the biosensor is configured to detect a first resistance measurement and a second resistance measurement, wherein the spino-cerebral endothelial cells are immobilized on the portion of the top surface of the working electrode during both the first resistance measurement and the second resistance measurement.

2. The biosensor according to claim 1 , wherein the working electrode is formed on a first substrate of the at least one substrate and the reference electrode is formed on a second substrate of the at least one substrate.

3. The biosensor according to claim 1 , wherein the at least one substrate comprises glass, silicone, or a polymer.

4. The biosensor according to claim 1 , wherein at least a portion of the case is transparent.

5. The biosensor according to claim 1 , further comprising a second working electrode and a second reference electrode.

6. A method of detecting a change in transepithelial/transendothelial electrical resistance of spino-cerebral endothelial cells comprising:

providing a biosensor having:

at least one substrate;

an adhesion layer that overlies the at least one substrate, wherein the adhesion layer includes tantalum, chromium, tantalum nitride, tungsten-titanium, titanium, titanium nitride, or a combination thereof;

a working electrode that overlies the adhesion layer and is formed on at least a portion of the at least one substrate, the working electrode comprising a biologically inert material;

a reference electrode that overlies the adhesion layer and is formed on the at least one substrate; and

a case, wherein the case defines side walls, a lower wall, and a channel, wherein the channel has a volume of about 150 microliters or less and contacts the working electrode, further wherein the channel extends between at least one inlet and at least one outlet, the at least one inlet having a tapered and/or conical shape and the at least one outlet having a tapered and/or conical shape, further wherein the at least one inlet and the at least one outlet have an innermost part and an outermost part, the outermost part of the at least one inlet and the at least one outlet having a larger diameter than the innermost part of the at least one inlet and the at least one outlet;

wherein the adhesion layer is positioned between the at least one substrate and the working electrode and/or the reference electrode;

wherein the spino-cerebral endothelial cells are immobilized with at least one linking agent, wherein the at least one linking agent comprises a thiol, a pyrene, a diazonium, an azide, a sol-gel, or a combination thereof, and further wherein the at least one linking agent continuously covers a portion of a top surface of the working electrode, a side surface of the working electrode, and a portion of a top surface of the substrate, and further wherein at least the portion of the working electrode wherein the spino-cerebral endothelial cells are immobilized is transparent having a percent transmittance of at least 80% but no more than about 99.9%;

conducting a first resistance measurement by measuring a voltage at the working electrode across the spino-cerebral endothelial cells;

contacting the working electrode with a biological sample; and

conducting a second resistance measurement by measuring the voltage at the working electrode across the spino-cerebral endothelial cells.

7. The method of claim 6 , wherein the biological sample has a volume of about 1 μL to about 500 μL.

8. The method of claim 7 , wherein the biological sample has a volume of about 15 μL to about 100 μL.

9. The method of claim 6 , wherein the biological sample is mammalian spino-cerebral fluid or blood serum.

10. The method of claim 6 , wherein the biological sample is introduced into the biosensor via the at least one inlet.

Assignments (2)

Continuity (2)

References Cited (157)